China’s Everest starts first phase operations to make mRNA vaccines
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
A third of the world’s population has still not received a single dose of the Covid-19 vaccine, including 83% of all Africans, according.
The Indian drug regulator had given its nod for Tergene, a joint venture of Aurobindo Pharma, to make a vaccine to fight pneumonia,.
Advent International, a global private equity investor, will buy a 50.1% stake in India’s Suven Pharmaceuticals for INR 63,130 million ($762 million), according.
Alembic Pharma receives USFDA approval for breast cancer drug--Fulvestrant injection
A large pragmatic trial showed that two thiazide diuretics medicines showed the same effect on hypertension
FDA amends Plan B contraceptive pill label to state that it does not harm a fertilized egg and is not an abortion drug
BioNTech company starts trial for mRNA based malaria vaccine
Frequency therapeutics, a a biotech company is working on a drug to treat hearing loss and has got some good trial results
Roche's Actemra is the first FDA-approved monoclonal antibody to treat COVID-19